A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samples

Journal of Immunological Methods

Volumn 387, Issue 1-2, 2013, Pages 1-10

  Belabani, Chahrazed ^a   Rajasekharan, Sathyanath ^a   Poupon, Viviane ^a   Johnson, Trina ^a   Bar Or, Amit ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Accuracy; Multiplex; Precision; Sensitivity; Validation; Working range

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; POLYSTYRENE;

ACCURACY; ARTICLE; CLINICAL IMMUNOLOGY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOKINE RELEASE; DIAGNOSTIC KIT; HUMAN; IMMUNOASSAY; LABORATORY TEST; LIMIT OF QUANTITATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TRANSLATIONAL RESEARCH; VALIDATION STUDY;

CLINICAL LABORATORY TECHNIQUES; COST-BENEFIT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

EID: 84871434173     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.08.002     Document Type: Article

References (18)

1. Berthoud T.K., Manaca M.N., Quelhas D., Aguilar R., Guinovart C., Puyol L., Barbosa A., Alonso P.L., Dobano C. Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology. Malar. J. 2011, 10:115.
2. CDER, C.f.D.E.a.R., U.S.D.o.H.a.H.Services, F.a.D.Administration, C.f.V.M.(CVM) Guidance for industry on bioanalytical method validation: availability. Fed. Regist. 2001, 66:28526.
3. de Jager W., Rijkers G.T. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006, 38:294.
4. dupont N.C., Wang K., Wadhwa P.D., Culhane J.F., Nelson E.L. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J. Reprod. Immunol. 2005, 66(2):175.
5. Food and Drug Administration FDA Guidance for Industry: Bioanalytical Method Validation 2001, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD.
6. Greene J. Automating Magnetic Bead Multiplexing Assays. Genet. Eng. Biotechnol. News 2009, 29.
7. Khan S.S., Smith M.S., Reda D., Suffredini A.F., McCoy J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin. Cytom. 2004, 61:35.
8. Khan I.H., Krishnan V.V., Ziman M., Janatpour K., Wun T., Luciw P.A., Tuscano J. A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin. Cytom. 2009, 76:159.
9. Lee J.W. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics. Bioanalysis 2009, 1:1461.
10. Lee J.W., Weiner R.S., Sailstad J.M., Bowsher R.R., Knuth D.W., O'Brien P.J., Fourcroy J.L., Dixit R., Pandite L., Pietrusko R.G., Soares H.D., Quarmby V., Vesterqvist O.L., Potter D.M., Witliff J.L., Fritche H.A., O'Leary T., Perlee L., Kadam S., Wagner J.A. Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report. Pharm. Res. 2005, 22:499.
11. Lee J.W., Devanarayan V., Barrett Y.C., Weiner R., Allinson J., Fountain S., Keller S., Weinryb I., Green M., Duan L., Rogers J.A., Millham R., O'Brien P.J., Sailstad J., Khan M., Ray C., Wagner J.A. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 2006, 23:312.
12. Marks V. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin. Chem. 2002, 48:2008.
13. Nechansky A., Grunt S., Roitt I.M., Kircheis R. Comparison of the calibration standards of three commercially available multiplex kits for human cytokine measurement to WHO standards reveals striking differences. Biomark. Insights 2008, 3:227.
14. Pickering J.W., Martins T.B., Schroder M.C., Hill H.R. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b. Clin. Diagn. Lab. Immunol. 2002, 9:872.
15. Prabhakar U., Eirikis E., Reddy M., Silvestro E., Spitz S., Pendley C., Davis H.M., Miller B.E. Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants. J. Immunol. Methods 2004, 291:27.
16. Probst M., Rothe G., Schmitz G. Bead-based multiplex analysis. Lab. Med. 2003, 27:182.
17. Proctor B., Chen Y., Harkins P., Rose T., Mistry J., Xiao Q. Miliplex Mag immunoassays using Luminex magnetic beads 2010.
18. Ray C.A., Bowsher R.R., Smith W.C., Devanarayan V., Willey M.B., Brandt J.T., Dean R.A. Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J. Pharm. Biomed. Anal. 2005, 36:1037.